CONMED CNMD Tax expense on reclassification of realized net derivative loss to net income
Tax expense on reclassification of realized net derivative loss to net income at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's tax expense on reclassification of realized net derivative loss to net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CONMED's tax expense on reclassification of realized net derivative loss to net income?
- CONMED (CNMD) reported tax expense on reclassification of realized net derivative loss to net income of -$20K in Q1 2026.
- How has CONMED's tax expense on reclassification of realized net derivative loss to net income changed year-over-year?
- CONMED's tax expense on reclassification of realized net derivative loss to net income decreased by 107.1% year-over-year, from $282K to -$20K.
- What is the long-term trend for CONMED's tax expense on reclassification of realized net derivative loss to net income?
- Over 3 years (2021 to 2024), CONMED's tax expense on reclassification of realized net derivative loss to net income has grown at a 10.6% compound annual growth rate (CAGR), from -$969K to $1.31M.
- What does tax expense on reclassification of realized net derivative loss to net income mean?
- This measures the tax expense or benefit associated with the reclassification of realized derivative gains or losses from equity into the income statement. It ensures that the impact of hedging on net income is presented on an after-tax basis.